pancreatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with acute pancreatitis. 2.Patients classified as mild to moderate according to the revised Atlanta criteria, as determined by the physician (criteria details are shown in Tables 1 and 2). 3.Patients who voluntarily agree to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients meeting any of the following conditions will be excluded:Known history of severe cardiovascular, respiratory, renal, gastrointestinal/liver, hematologic/tumor, or immune diseases, defined as: (1) Heart failure greater than New York Heart Association Class II. (2) Active myocardial ischemia. (3) Chronic kidney disease with serum creatinine greater than 2.0 mg/dL. (4) Chronic obstructive pulmonary disease requiring supplemental oxygen. (5) Gastrointestinal motility disorders or inflammatory bowel disease. (6) History of cirrhosis. (7) Active malignancies, except non-squamous skin cancer. 2.Exclusion of patients with a history of chronic pancreatitis or chronic pain syndrome in the 30 days prior to hospitalization, those requiring narcotic pain medications, or those who have been recently prescribed opioid drugs. Patients who have had abdominal surgery within the last 60 days will also be excluded. 3.Pregnant women. 4.Patients diagnosed with paralytic ileus by CT on admission. 5.Patients with concurrent cholangitis or cholecystitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| inflammation biomarker;albumin; | — |
Secondary
| Measure | Time frame |
|---|---|
| intestinal flora;hospital stay; | — |
Countries
China
Contacts
Mianyang Central Hospital